About the Journal

Submissions

Submissions should be made through the system: http://www.ojs.ufpi.br/index.php/nupcis  with your login and password. To submit the text, all authors must be registered with the Journal of Infection Prevention and Health, and all information must be correctly filled out in the submission metadata.

We welcome manuscripts addressing research, epidemiology, and clinical aspects of infectious diseases, intending to be a reliable source for both academics and healthcare professionals worldwide.

We publish manuscripts in the following categories: original articles, reviews, and clinical case reports, which meet the publication standards of REPIS, emphasizing the importance of clear and accessible language to ensure the applicability of knowledge in clinical practice.

Alignment with International Ethical Principles

REPIS follows the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals by ICMJE and the ethical guidelines of COPE. For research involving humans, approval from an Ethics Committee and protocol submission is required.

Studies conducted outside Brazil must adhere to the ethical principles of the Helsinki Declaration.

Research involving animals requires ethical approval and compliance with the Guide for the Care and Use of Laboratory Animals and COBEA guidelines.

REPIS uses the Turnitin platform to detect plagiarism, self-plagiarism, and high similarity.

Indexing Sources

 

Editorial Policy

Peer Review

Pre-evaluation:

Immediately after submission, the managing/editor-in-chief conducts a technical check to assess the overall suitability of the manuscript for the journal's scope, adherence to ethical and quality standards, and necessary rigor to proceed to detailed evaluation.

Review:

After initial checks, the manuscript is sent to at least two independent experts for review, following the double-blind review model. Reviewer comments are confidential unless there is explicit agreement for disclosure.

REPIS adopts two evaluation systems:

1. Articles published in Pre-print repositories: an open review is adopted, where reviewers know the authors' names.

2. Traditional Articles: Double-blind review, ensuring anonymity between authors and reviewers, following the journal's standards for ethical integrity.

Thus, manuscripts that have been made available in pre-print repositories will be analyzed through the "open-peer review" system. In this system, reviewers will have access to the authors' names, providing greater transparency to the process.

It is necessary to inform in the Cover Letter, as well as in "editor comments" that it is a manuscript hosted in a pre-print repository, as well as the DOI of the pre-print submission.

Manuscripts from members of the journal's editorial board will necessarily only be analyzed through this mechanism to ensure ethical integrity.

Possible Editorial Decisions

  • Immediate rejection (before peer review): When the text lacks sufficient scientific originality to be sent to reviewers or when it does not fit within the journal's scope.
  • Minor revisions: The manuscript needs few changes, taking little time (between 5 and 10 days) and involving less than half of the manuscript's sections.
  • Major revisions: The manuscript needs many changes, taking a long time (between 11 and 20 days) and involving 75% of the manuscript's sections. In this case, significant changes in the method and results are not necessary, i.e., it is not necessary to completely redo tables or redo experiments and statistical tests.
  • Reject and resubmit: The manuscript needs many changes, especially significant changes in the method and results, i.e., it is necessary to completely redo tables or redo experiments and statistical tests. These changes would take more than a month, but the manuscript is interesting for REPIS.
  • Reject: After peer review, the reviewers pointed out a lack of originality or significant misunderstandings that will not be overcome by revisions.

Appeals against a Decision

Authors can appeal editorial decisions by sending an email to the REPIS Editorial Office, provided that the manuscript has undergone at least one round of peer review. The appeal must contain a detailed justification, including responses to reviewer or Editor comments. The Editor-in-Chief forwards the manuscript to an Associate Editor and a member of the Editorial Board for analysis. The decision of rejection after this process is final.

Privacy Policy

The names and addresses provided in this journal will be used exclusively for the services provided by this publication, not being made available for other purposes or to third parties.

Ethics and Misconduct Policy:

REPIS adopts COPE's ethical guidelines and follows the flowchart provided by the committee to assess cases of misconduct. Depending on the decision of the Editorial Board, measures may include embargo, publication suspension, or retraction of the manuscript. Authors are informed of each step and the final decision.

Data Sharing and Reproducibility: REPIS encourages authors to make data and supporting materials available, adhering to international standards of reproducibility and scientific transparency. It is recommended that research data—such as reports, software, codes, and methodologies—be deposited in public data repositories. Preferably, free and internationally recognized repositories should be used to ensure broad and easy access to data.

Conflict of Interest Policy:

All authors, reviewers, and editors must declare potential conflicts of interest, including financial, academic, or personal conflicts. Conflicts do not prevent publication but must be disclosed during manuscript submission.

Copyright:

REPIS authors retain the copyright to their work under the Creative Commons CC-BY (4.0) license, allowing reuse and distribution provided that the original work is properly cited. The journal holds the right of first publication.

Intellectual Property and Terms of Use:

All content in REPIS is licensed under Creative Commons Attribution. The journal encourages authors to self-archive their accepted manuscripts on their social networks, provided they include the complete citation of the published version on the journal's website.

Post-Publication Discussions and Corrections: REPIS accepts discussions, letters to the editor, critiques, and post-publication corrections. The journal has mechanisms for errata, retractions, or expressions of concern, which are reviewed by the executive board. Necessary corrections are handled in a way that ensures authors' responses when needed.

Frequency

Since January 2018, the journal has adopted the continuous publication system (rolling pass).

Open Access Policy

This journal offers immediate open access to its content, following the principle that freely providing scientific knowledge to the public promotes greater worldwide democratization of knowledge.

Processing Fees

REPIS does not charge submission or manuscript processing fees. However, the layout and translation of the manuscript are provided by third-party companies indicated by REPIS.

Archiving

This journal uses the LOCKSS system to create a distributed archiving system among participating libraries and allows them to create permanent archives of the journal for preservation and restoration.

Previous Editions

Publications from 2015 to 2021 are hosted on the old website, to access click here.

Highly Cited Papers (2023):

Titulo

Quantidade de citações

Ano de publicação

RESISTÊNCIA BACTERIANA À ANTIBIÓTICOS NA UNIDADE DE TERAPIA INTENSIVA: REVISÃO INTEGRATIVA

33

2018

ASSISTÊNCIA DE ENFERMAGEM NO PARTO HUMANIZADO

33

2018

COVID-19: ORIGIN, PATHOGENESIS, TRANSMISSION, CLINICAL ASPECTS AND CURRENT THERAPEUTIC STRATEGIES

20

2020

COVID-19: ANALYSIS OF CONFIRMED CASES IN TERESINA, PIAUI, BRAZIL

20

2020

ASSISTÊNCIA DE ENFERMAGEM À GESTANTE DE ALTO RISCO SOB A VISÃO DO PROFISSIONAL

18

2018

HOW CAN COVID-19 PANDEMIC AFFECT MEN'S HEALTH? A SOCIOHISTORIC ANALYSIS

18

2020

PERFIL EPIDEMIOLÓGICO DOS CASOS DE TUBERCULOSE NO ESTADO DO MARANHÃO NOS ANOS DE 2012 A 2016

15

2018

PERFIL EPIDEMIOLÓGICO DE TUBERCULOSE EM PACIENTES PORTADORES DE HIV

15

2018